ストックスクリーナーアプリを入手
6.30
0.80%
0.05
前日終値:
$6.25
開ける：
$6.25
24時間の取引高:
14,683
Relative Volume:
0.09
時価総額：
$46.14M
収益：
$7.00M
当期純損益:
$-70.79M
株価収益率:
-0.6502
EPS:
-9.69
ネットキャッシュフロー:
$-64.34M
1週間 パフォーマンス:
+0.16%
1か月 パフォーマンス:
+0.80%
6か月 パフォーマンス:
+38.46%
1年 パフォーマンス:
-8.03%
1日の値動き範囲:
$6.25
$6.33
1週間の範囲:
$6.23
$6.33
52週間の値動き範囲:
$3.5334
$6.91
Kezar Life Sciences Inc Stock (KZR) Company Profile
名前
Kezar Life Sciences Inc
セクター
電話
650-822-5600
住所
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
KZR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
6.30 | 45.77M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-17 | ダウングレード | Jefferies | Buy → Hold |
| 2025-10-17 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-08-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | 開始されました | Wells Fargo | Overweight |
| 2018-07-16 | 開始されました | Jefferies | Buy |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
| 2018-07-16 | 開始されました | William Blair | Outperform |
すべてを表示
Kezar Life Sciences Inc (KZR) 最新ニュース
Discontinued operations of Kezar Life Sciences Inc – GETTEX:2KZ0 - TradingView — Track All Markets
What drives Kezar Life Sciences Inc stock priceGap Up/Gap Down Analysis & Free High Yield Investment Strategies - earlytimes.in
Financial Contrast: BioXcel Therapeutics (NASDAQ:BTAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know - sharewise.com
Forecast Cut: Why Kezar Life Sciences Inc stock is seen as undervalued2025 Price Momentum & Daily Chart Pattern Signal Reports - moha.gov.vn
Kezar Life Sciences Inc. (KZR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kezar Life Sciences, Inc. (NASDAQ:KZR) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Kezar Life Sciences (NASDAQ:KZR) Shares Down 0.3% – Here’s Why - Defense World
Is Dhunseri Tea Industries Limiteds Business Expansion Justified by Stock ValuationInstitutional Buying Trends & Low Cost Portfolio Ideas - earlytimes.in
Is Kezar Life Sciences, Inc. overvalued or undervalued? - Markets Mojo
Return on assets % of Kezar Life Sciences Inc – GETTEX:2KZ0 - TradingView — Track All Markets
Why Kezar Life Sciences Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - Улправда
Can Kezar Life Sciences Inc. stock deliver consistent earnings growthMarket Movement Recap & Free High Return Stock Watch Alerts - Улправда
How rising interest rates impact Kezar Life Sciences Inc. stockQuarterly Portfolio Review & Fast Gain Stock Trading Tips - Улправда
How Kezar Life Sciences Inc. stock benefits from tech adoptionGap Up & Verified Swing Trading Watchlist - Улправда
How Kezar Life Sciences Inc. (2KZ0) stock trades pre earningsAnalyst Downgrade & Community Consensus Trade Signals - DonanımHaber
How Kezar Life Sciences Inc. stock performs in rate cut cycles2025 Retail Activity & Long-Term Growth Portfolio Plans - Bölüm Sonu Canavarı
Will Kezar Life Sciences Inc. stock deliver better than expected guidanceQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - Улправда
Is Kezar Life Sciences Inc. (2KZ0) stock a good hedge against inflationStop Loss & Weekly Breakout Opportunity Watchlist - Улправда
Kezar Life Sciences Earnings Notes - Trefis
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Reviewing Dyadic International (NASDAQ:DYAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Can Kezar Life Sciences Inc. (2KZ0) stock beat analyst consensusJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
How Kezar Life Sciences Inc. (2KZ0) stock compares with market leadersJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
Kezar Life Sciences (KZR) Stock Analysis Report | Financials & Insights - Benzinga
Will Kezar Life Sciences Inc. (2KZ0) stock sustain uptrend momentumMarket Movement Recap & Fast Entry Momentum Alerts - Newser
Kezar Life Sciences Reports Q3 2025 Financial Results - MSN
How institutional buying supports Kezar Life Sciences Inc. stockJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
How supply chain issues affect Kezar Life Sciences Inc. stockJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Kezar Life Sciences Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Top chart patterns to watch in Kezar Life Sciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com
Is Kezar Life Sciences Inc. stock a safe haven assetSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock a buy for dividend portfoliosMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock ideal for retirement investorsTreasury Yields & Real-Time Chart Pattern Alerts - newser.com
How Kezar Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Will Kezar Life Sciences Inc. (2KZ0) stock attract long term capital inflows - newser.com
Will Kezar Life Sciences Inc. stock continue upward momentumWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Kezar Life Sciences Initiates Major Overhaul Following Regulatory Setback - Ad-hoc-news.de
Equities Analysts Set Expectations for KZR FY2025 Earnings - Defense World
Kezar Life Sciences, Inc. (KZR) AI-Powered Stock Analysis - Meyka
Will Kezar Life Sciences Inc. stock beat EPS estimatesJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Kezar Life Sciences Inc (KZR) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):